Oxaloacetate

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Oxaloacetate or oxaloacetic acid (OAA) or Anhydrous Enol-Oxaloacetate or (AEO), also available under the brand name Jubilance, is nutritional supplement currently under investigation as a treatment for chronic fatigue and mental fatigue in ME/CFS[1] and Long COVID.[2] The Jubilance brand has limited evidence that it "may help alleviate the mild to moderate psychological and/or behavioral symptoms associated with Premenstrual Syndrome (PMS)".[3]

Theory[edit | edit source]

Oxaloacetate is part of the Citric acid cycle and is formed from pyruvate. It is crucial in replenishing the citric acid cycle by acting as an acceptor for Acetyl coenzyme A.[4] Additional oxaloacetate may provide mitochondrial support in ME/CFS.[citation needed]

Evidence[edit | edit source]

In 2022, Cash et al. (2022) reported:

"Anhydrous Enol-Oxaloacetate, (AEO) a nutritional supplement, has been anecdotally reported to relieve physical and mental fatigue and is dimished in ME/CFS patients. Here, we examine the use of higher dosage AEO as a medical food to relieve pathological fatigue."

"76 ME/CFS patients (73.7% women, median age of 47) showed an average reduction in fatigue at 6 weeks as measured by the "Chalder Fatigue Questionnaire" of 22.5% to 27.9% from baseline (P < 0.005) (Likert scoring).

Clinicians[edit | edit source]

Risks and safety[edit | edit source]

Costs and availability[edit | edit source]

Notable studies[edit | edit source]

  • 2022, Oxaloacetate Treatment For Mental And Physical Fatigue In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long-COVID fatigue patients: a non-randomized controlled clinical trial[5] - (Full text)

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]